Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOAH
2601
Noah Holdings
NOAH
$559M
| $3.82M | ﹤0.01% |
382,663
-85,847
| -18% | -$884K |
|
|
GLIBA
2602
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.03B
| $3.82M | ﹤0.01% |
174,376
+20,187
| +13% | +$571K |
|
2603
Novavax
NVAX
$1.52B
| $3.74M | ﹤0.01% |
396,711
+384,864
| +3,249% | +$3.45M |
|
2604
Finance of America Companies
FOA
$136M
| $3.73M | ﹤0.01% |
135,623
+33,562
| +33% | +$685K |
|
|
DRD
2605
DRDGold
DRD
$2.22B
| $3.7M | ﹤0.01% |
173,575
+4,102
| +2% | +$111K |
|
2606
Envela
ELA
$338M
| $3.69M | ﹤0.01% |
127,881
+41,428
| +48% | +$923K |
|
2607
GDS Holdings
GDS
$6.1B
| $3.69M | ﹤0.01% |
122,887
-71,784
| -37% | -$2.77M |
|
2608
Tenax Therapeutics
TENX
$68.5M
| $3.69M | ﹤0.01% |
253,518
+190,732
| +304% | +$2.44M |
|
2609
Nice
NICE
$6.09B
| $3.67M | ﹤0.01% |
40,367
-491
| -1% | -$47.6K |
|
2610
Perspective Therapeutics
CATX
$312M
| $3.66M | ﹤0.01% |
1,074,071
+623,974
| +139% | +$2.36M |
|
|
OKLO
2611
Oklo
OKLO
$6.69B
| $3.59M | ﹤0.01% |
68,694
-73,788
| -52% | -$4.6M |
|
|
WSO.B
2612
Watsco Inc Class B
WSO.B
$12.9B
| $3.59M | ﹤0.01% |
10,265
| – | – |
|
|
DGICB
2613
Donegal Group Class B
DGICB
$928M
| $3.59M | ﹤0.01% |
164,816
-52
| -0% | -$1.01K |
|
|
NOA
2614
North American Construction
NOA
$353M
| $3.58M | ﹤0.01% |
269,536
+69,288
| +35% | +$978K |
|
2615
ENI
E
$81.4B
| $3.52M | ﹤0.01% |
75,062
-8,370
| -10% | -$449K |
|
2616
Fulcrum Therapeutics
FULC
$288M
| $3.52M | ﹤0.01% |
960,547
-169,734
| -15% | -$1.03M |
|
2617
DMC Global
BOOM
$130M
| $3.5M | ﹤0.01% |
602,455
-49,383
| -8% | -$321K |
|
2618
Priority Technology Holdings
PRTH
$495M
| $3.49M | ﹤0.01% |
522,340
+85,201
| +19% | +$493K |
|
2619
Ginkgo Bioworks
DNA
$471M
| $3.48M | ﹤0.01% |
351,200
+224,152
| +176% | +$1.87M |
|
2620
JD.com
JD
$36.6B
| $3.43M | ﹤0.01% |
134,786
-33,570
| -20% | -$989K |
|
2621
Greene County Bancorp
GCBC
$613M
| $3.42M | ﹤0.01% |
101,947
+9,340
| +10% | +$240K |
|
2622
Lakeland Industries
LAKE
$104M
| $3.42M | ﹤0.01% |
320,235
-8,909
| -3% | -$89.9K |
|
2623
Pro-Dex
PDEX
$214M
| $3.34M | ﹤0.01% |
57,061
+120
| +0.2% | +$6.97K |
|
2624
Crexendo
CXDO
$187M
| $3.32M | ﹤0.01% |
444,639
+64,312
| +17% | +$503K |
|
2625
Phreesia
PHR
$642M
| $3.3M | ﹤0.01% |
321,130
-163,587
| -34% | -$1.52M |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.